Sanguine
Biotechnology, 400 W Cummings Park, Woburn, Massachusetts, 01801, United States, 51-200 Employees
Phone Number: 85********
Who is SANGUINE
Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. Sanguine actively bridg...
Read More
- Headquarters: 400 W Cummings Park, Woburn, Massachusetts, 01801, United States
- Date Founded: 2010
- Employees: 51-200
- Revenue: $50 Million to $100 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836 | NAICS Code: 561110 | Show More
Sanguine Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Sanguine
Answer: Sanguine's headquarters are located at 400 W Cummings Park, Woburn, Massachusetts, 01801, United States
Answer: Sanguine's phone number is 85********
Answer: Sanguine's official website is https://sanguinebio.com
Answer: Sanguine's revenue is $50 Million to $100 Million
Answer: Sanguine's SIC: 2836
Answer: Sanguine's NAICS: 561110
Answer: Sanguine has 51-200 employees
Answer: Sanguine is in Biotechnology
Answer: Sanguine contact info: Phone number: 85******** Website: https://sanguinebio.com
Answer: Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data and facilitating participation in biomedical research. Sanguine actively bridges the gap between patients and researchers through direct-to-patient engagement, in-home collection of fully annotated biospecimens, apheresis product offerings, and a suite of biorepository services. Sanguine has supported translational, clinical, and cell & gene therapy research at 35 of the top 40 global pharmaceutical and biotechnology companies, shortening timelines and validating early-stage results to increase confidence and refine biomarkers in human trials. Four years in a row, Sanguine received the prestigious designation of a Great Places to Work company. In 2022, Sanguine was designated #2038 on the Inc. 5000 Americas Fastest Growing Private Companies list and achieved recognition on FORTUNEs 100 Best Small Workplaces and Best Workplaces in Biopharma. Referenced in over 140 publications, Sanguine studies have appeared in high-impact journals, including Science, Nature, NEJM, Nature Medicine, and Science Translational Medicine. Popular media outlets featuring Sanguine include the Fox News Channel, The Washington Post, Inc.,The Boston Globe, Inc., and many others.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month